Merck is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
If authorized, the drug would be the first oral antiviral treatment to fight Covid-19.
CNN’s Elizabeth Cohen reports.
Merck seeks FDA emergency use authorization for antiviral COVID-19 treatment molnupiravir
WXYZ Detroit
Pharmaceutical giant Merck has applied for Emergency Use Authorization for its promising antiviral COVID-19 treatment. If the FDA..
